Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US

The US, with its healthcare spending crossing US$ 2.2 Trillion in 2007, represents the most important healthcare product and services market in the world. And according to "Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US", the new research report from RNCOS, the potential and opportunities in this market are expected to increase several fold in the next five years.

This report provides factual insight supplemented with statistical overview on the past, present and future market. It studies the entire structure, composition and working of the US healthcare sector and describes the potential of hospital services, pharmaceuticals and medical devices in the market. This report discusses the demand, market size and future prospects of nearly every major sector, like cardiovascular, diabetes, musculoskeletal, oncology, wound care management, cosmetic surgery, dental health, and in vitro diagnostics, in the US healthcare market. It identifies key opportunities and roadblocks that will affect the future direction of the market.

"Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US" thus serves as a guide for healthcare service providers/drug manufactures/investors who are planning to enter the US healthcare market as it helps in identifying and analyzing market opportunities that will suit their business needs and profiles.

Key Findings of the Report

* Total healthcare spending in the US is expected to grow at a CAGR of 7% between 2007 and 2012.
* Around 43 Million people are expected to be above 65 years of age in the US by 2012, thereby increasing the prevalence of several chronic diseases.
* Around 122 Million Americans are expected to suffer from cardiovascular diseases by 2012, leading to direct expenses of over US$ 414 Billion.
* The US, with over 19 Million diabetics by 2012, is expected to fuel the growth of the diabetes drugs and monitoring devices market.
* Driven by target-based therapies with negligible side effects, the US oncology market is amongst the fastest growing sectors in the healthcare industry.
* The aging baby boomers, coupled with an increasing incidence of hip and knee fractures, are expected to strongly drive the musckoskeletal market.
* Driven by a need to look young and attractive, both surgical and non-surgical cosmetic procedures are becoming highly popular.

Key Issues & Facts Analyzed in the Report

* Evaluation of past, current and future market trends.
* Market evaluation by type of disease.
* Discussion on the major drivers of the healthcare market.
* Identification and evaluation of the opportunities created by the market.
* Analysis of major challenges for the market.

Research Methodology Used in the Report

Information Sources
Information has been sourced from books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to over 3000 paid databases.

Analysis Methods
RNCOS industry forecast and analysis is based on various macro- and microeconomic factors, sector and industry specific databases, and our in-house statistical and analytical model. This model takes into account the past and current trends in an economy, and more specifically in an industry, to bring out an objective market analysis.

Our industry experts study the relationship between various industry and economic variables to ensure the required accuracy and desired check on the quality of data and information given in the report.